19341-54-9 Usage
Uses
Used in Scientific Research:
N-Ethylguanidine Hydrochloride is used as a research chemical for various applications in the field of scientific research. Its unique properties, such as solubility and melting point, can be manipulated to suit specific research needs.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, N-Ethylguanidine Hydrochloride is used as an intermediate compound in the synthesis of various drugs. Its chemical structure allows for the development of new therapeutic agents with potential applications in treating different medical conditions.
Used in Chemical Synthesis:
N-Ethylguanidine Hydrochloride is employed as a reagent in the synthesis of other chemical compounds. Its versatility in chemical reactions makes it a valuable component in the production of various organic compounds for industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 19341-54-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,3,4 and 1 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 19341-54:
(7*1)+(6*9)+(5*3)+(4*4)+(3*1)+(2*5)+(1*4)=109
109 % 10 = 9
So 19341-54-9 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N5O6PS/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(21-10)1-20-22(18,19)23/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,23)/p-2/t4-,6-,7-,10-/m1/s1
19341-54-9Relevant academic research and scientific papers
PROCESS FOR STRAIGHTENING KERATIN FIBRES WITH A HEATING MEANS AND DENATURING AGENTS
-
, (2010/03/02)
The invention relates to a process for straightening keratin fibres, comprising: (i) a step in which a straightening composition containing at least two denaturing agents is applied to the keratin fibres, (ii) a step in which the temperature of the keratin fibres is raised, using a heating means, to a temperature of between 110 and 250° C.
Method of treating coccidiosis with acyl guanidines
-
, (2008/06/13)
Methods for the treatment of physiological disorders, including protozoal infections in mammalian and avian species and gastrointestinal and cardiovascular disorders in mammalian species by administering a class of aralkyl- and aralkenyl-acyl, and thioacyl, guanidine compounds, pharmaceutical compositions containing such compounds for systemic administration, and a class of novel aralkenyl-, aryl-substituted cycloalkyl-, and arylsubstituted heterocycle-acyl and thioacyl guanidines.
